TSE:4502Pharmaceuticals
Takeda Leadership Shakeup Puts Focus On Pipeline Progress And Capital Decisions
Takeda Pharmaceutical (TSE:4502) announced that CEO Christophe Weber plans to retire in June 2026.
Several members of Takeda’s Board of Directors are also set to step down as part of a broader leadership refresh.
The company highlighted that this transition is being planned ahead of time while it continues to advance its drug pipeline.
As one of Japan’s largest pharmaceutical groups, Takeda is a key player in prescription medicines and research driven drug development. The planned...